Grand Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Grand Pharmaceutical Group has a total shareholder equity of HK$15.3B and total debt of HK$3.3B, which brings its debt-to-equity ratio to 21.8%. Its total assets and total liabilities are HK$22.5B and HK$7.2B respectively. Grand Pharmaceutical Group's EBIT is HK$2.6B making its interest coverage ratio 12.7. It has cash and short-term investments of HK$3.3B.
Key information
21.8%
Debt to equity ratio
HK$3.33b
Debt
| Interest coverage ratio | 12.7x |
| Cash | HK$3.27b |
| Equity | HK$15.27b |
| Total liabilities | HK$7.24b |
| Total assets | HK$22.52b |
Recent financial health updates
We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt
Oct 20
Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?
May 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Nov 21Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Aug 16Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet
Mar 22These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely
Dec 13Recent updates
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Apr 25Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Mar 25We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt
Oct 20Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Sep 26Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14
Jun 04Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?
May 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Nov 21Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?
Sep 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Aug 16Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Jul 28Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11
May 29Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?
Apr 08Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet
Mar 22If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late
Jan 24These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely
Dec 13Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price
Nov 27With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting
Oct 25China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly
Sep 01Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?
Jul 12We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Can Stay On Top Of Its Debt
Apr 26Calculating The Fair Value Of China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512)
Apr 08Here's Why We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Well Worth Watching
Mar 24If You Had Bought China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Shares Five Years Ago You'd Have Earned 332% Returns
Mar 11Are Robust Financials Driving The Recent Rally In China Grand Pharmaceutical and Healthcare Holdings Limited's (HKG:512) Stock?
Feb 22China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Are Growing But Is There More To The Story?
Jan 21Financial Position Analysis
Short Term Liabilities: 512's short term assets (HK$7.0B) exceed its short term liabilities (HK$5.7B).
Long Term Liabilities: 512's short term assets (HK$7.0B) exceed its long term liabilities (HK$1.5B).
Debt to Equity History and Analysis
Debt Level: 512's net debt to equity ratio (0.4%) is considered satisfactory.
Reducing Debt: 512's debt to equity ratio has reduced from 34.6% to 21.8% over the past 5 years.
Debt Coverage: 512's debt is well covered by operating cash flow (54.2%).
Interest Coverage: 512's interest payments on its debt are well covered by EBIT (12.7x coverage).